Literature DB >> 19233915

Counterpoint: pharmacogenetic-based initial dosing of warfarin: not ready for prime time.

Charles S Eby1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19233915     DOI： 10.1373/clinchem.2008.115972

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  2 in total

1.  Prediction of warfarin dose reductions in Puerto Rican patients, based on combinatorial CYP2C9 and VKORC1 genotypes.

Authors:  Isa Ivette Valentin; Joan Vazquez; Giselle Rivera-Miranda; Richard L Seip; Meredith Velez; Mohan Kocherla; Kali Bogaard; Iadelisse Cruz-Gonzalez; Carmen L Cadilla; Jessica Y Renta; Juan F Feliu; Alga S Ramos; Yirelia Alejandro-Cowan; Krystyna Gorowski; Gualberto Ruaño; Jorge Duconge
Journal:  Ann Pharmacother       Date:  2012-01-24       Impact factor: 3.154

2.  Next generation DNA sequencing and the future of genomic medicine.

Authors:  Matthew W Anderson; Iris Schrijver
Journal:  Genes (Basel)       Date:  2010-05-25       Impact factor: 4.096
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.